OTCM
BACK
Market cap2kUSD
Oct 08, Last price
0.00USD
1D
0.00%
1Q
-97.93%
IPO
-100.00%
Name
IMAC Holdings Inc
Chart & performance
P/E
—
P/S
0.03
EPS
—
Div yield, %
—
Shrs. gr., 5y
43.44%
Rev. gr., 5y
-65.68%
Revenues
72k
-98.61%
Net income
-9m
L-3.96%
CFO
-3m
L+13.33%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IMAC Holdings, Inc. operates a network of advanced medical and regenerative care centers across the United States, which it either owns, manages, or subleases. These outpatient clinics specialize in delivering innovative regenerative, orthopedic, and minimally invasive therapies. Their services are designed to address a range of conditions, including athletic injuries, damage to ligaments and tendons, other soft tissue ailments, and chronic back, knee, and joint pain. Additionally, the company offers physical therapy, spinal decompression, and chiropractic manipulation. Established in 2000 and based in Brentwood, Tennessee, IMAC Holdings, Inc. currently oversees or possesses 15 such outpatient medical facilities located in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida.
Key people
Faith Zaslavsky
Chief Executive Officer · since 2024
Sheri Gardzina
Chief Financial Officer · since 2017
Peter Beitsch
Director · since 2024
Jason Lobel
Director · since 2025
Saundra Pelletier
Director · since 2025
Matthew Schwartz
Director · since 2024
Independent Director · since 2024
Maurice Evans
Independent Director · since 2020
Legal address
C/O National Registered Agents, Inc.
160 Greentree Drive
Suite 101
Dover, DE 19904
US
160 Greentree Drive
Suite 101
Dover, DE 19904
US
Headquarters
1605 Westgate Circle
Brentwood, TN 37027
US
Brentwood, TN 37027
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||